Clinical Trials Browser

Hypertension, Portal × Clear all

NCT05027425 2026-05-06

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

Phase 2 Terminated

8 enrolled 9 charts

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal

NCT07252570 2025-11-26

Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes

Gastrointestinal

Biliary Tract Neoplasms, Hypertension, Portal, Pancreatic Neoplasms

NCT06265272 2025-09-26

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

NCT05339984 2025-06-27

LSM

Phase NA Recruiting

Fibrosis, Hypertension, Portal, Liver Diseases

NCT06594744 2025-02-13

P-HCC-CVL

Phase 4 Recruiting

Gastrointestinal

Esophageal and Gastric Varices, Carcinoma, Hepatocellular, Hypertension, Portal

NCT06773260 2025-01-22

ELASTO-HCC

Enrolling by invitation

Gastrointestinal

Esophageal and Gastric Varices, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

NCT06434753 2024-06-04

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT05502198 2023-08-24

ACCESS-ESLD

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis, Sarcopenia

NCT05703750 2023-05-31

Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT05704192 2023-05-31

CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT02192671 2022-01-18

HR-HCC/PHT

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Neoplasms, Neoplasms, Glandular and Epithelial

NCT05141617 2021-12-02

Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Hypertension, Portal

NCT01642446 2021-09-27

Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT04994548 2021-08-06

Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension

Gastrointestinal

Esophageal Neoplasms, Fibrosis, Hypertension, Portal

NCT04640116 2020-12-19

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Phase NA Unknown

Gastrointestinal

Ascites, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis, Liver Diseases

NCT04524650 2020-08-28

Early Diagnosis of Oxaliplatin-induced Portal Hypertension

Gastrointestinal

Hypertension, Portal, Splenomegaly, Colorectal Neoplasms

NCT04527666 2020-08-27

Anticoagulation in Gastroesophageal Varices and JAK2 Mutation

Hypertension, Portal, Myeloproliferative Disorders

NCT04525768 2020-08-25

Gastroesophageal Varices in Cavernoma

Hypertension, Portal, Myeloproliferative Disorders

NCT04524676 2020-08-24

Oxaliplatin-induced Portal Hypertension

Phase NA Unknown

Gastrointestinal

Hypertension, Portal, Splenomegaly, Colorectal Neoplasms

NCT01451658 2019-09-04

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01970748 2019-08-30

P-HCC

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT02145013 2018-02-12

Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT02305914 2015-05-22

FSCAP

Gastrointestinal

Autoimmune Pancreatitis, Diabetes Mellitus, Hypertension, Portal, Metabolic Diseases, Pancreatic Neoplasms, Pancreatitis, Respiratory Insufficiency, Pancreatitis, Chronic

NCT01298284 2011-06-15

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

NCT00280007 2010-04-22

Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal